Silvia Trasciatti
Chief Scientific Officer
Preclinical Research
Galileo Biotech
Italy
Biography
Silvia Trasciatti has served as Head of Preclinical Research in istituto Gentili S.p.A. (Pisa, Italy) and as Director of Research Center of Abiogen Pharma S.p.A. Since 2008 she has been R&D Division Director of Abiogen Pharma S.p.A. She is Member of the Scientific Advisory Board of Mediapharma S.r.L.. Silvia Trasciatti holds a graduate degree in Biological Sciences (University of Pisa), a post-graduate 3-year specialization degree in Biotechnology (University of Milano) and a Master in Nutritional Science (University of Firenze). She is member of the Advanced Therapies Working Group of the Scientific Committee in Farmindustria and of the Advanced Therapies Working Group in Assobiotec. Currently, she is Chief Scientific Officer in Galileo Research.
Research Interest
Biotechnology and Nutritional Science
